Suchergebnisse - "Schmitt, Andreas M"

PubPharm (35)

11

Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer

enthalten in: Cell reports. Medicine | 2022

von Fendler, A. | Shepherd, S. | Au, L. | +61

12

Hitting the sweet spot : optimal use of corticosteroids for immune checkpoint inhibitor side-effects

enthalten in: The Lancet. Oncology | 2022

von Schmitt, A. | Spain, L. | Larkin, J.

13

Patient-reported outcomes : what really matters to patients?

enthalten in: The Lancet. Oncology | 2022

von Hasanov, E. | Caceres, J. | Maskens, D. | +2

CommentOn: Lancet Oncol. 2022 Feb;23(2):292-303. - PMID 35032437

14

Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients : Final Results of SAKK 80/20 (CaSA)

enthalten in: Cancers | 2022

von Joerger, M. | Metaxas, Y. | Zaman, K. | +18

15

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer

enthalten in: Cancer cell | 2022

von Fendler, A. | Shepherd, S. | Au, L. | +63

ErratumFor: Cancer Cell. 2022 Feb 14;40(2):114-116. - PMID 34968417

16

Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

enthalten in: Lancet (London, England) | 2022

von Fendler, A. | Shepherd, S. | Au, L. | +59

CommentOn: Cancer Cell. 2022 Feb 14;40(2):114-116. - PMID 34968417

17

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer

enthalten in: Cancer cell | 2022

von Fendler, A. | Shepherd, S. | Au, L. | +62

CommentIn: Lancet. 2022 Mar 5;399(10328):905-907. - PMID 35090602

18

Atezolizumab, cobimetinib, and vemurafenib as first-line treatment for unresectable metastatic BRAF V600 mutated melanoma

enthalten in: Expert review of anticancer therapy | 2022

von Schmitt, A. | Dumas, L. | Larkin, J.

19

Immune responses following third COVID-19 vaccination are reduced in patients with hematologic malignancies compared to patients with solid cancer

enthalten in: ResearchSquare.com | 2021

von Fendler, A. | Shepherd, S. | Au, L. | +59

20

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer : The CAPTURE study

enthalten in: Nature cancer | 2021

von Fendler, A. | Shepherd, S. | Au, L. | +94